Innovative molecular matching platform for research centers, pharmaceutical companies, and biotech firms, with GPU acceleration and customizable workflows.
Research centers, pharmaceutical companies, and biotech firms struggle with analyzing large-scale molecular interactions efficiently due to the lack of optimized frameworks.
Massive Molecular Matching S.r.l. (EM3) develops an innovative framework for large-scale molecular matching and simulation, leveraging graph-based algorithms optimized for heterogeneous architectures with GPU acceleration.
1. Number of research centers, pharmaceutical companies, and biotech firms using the platform
2. Efficiency improvement in molecular interaction analysis
3. API integration rate
EM3 offers high performance computing capabilities, customizable workflows, and seamless integration with diverse computational environments for drug discovery, materials science, and biotech innovation.
EM3's platform is optimized for heterogeneous architectures with GPU acceleration, providing a competitive edge in efficiency and scalability for molecular interaction analysis.
1. Direct sales to research centers, pharmaceutical companies, and biotech firms
2. Online marketing and webinars to showcase the platform's capabilities
Research centers, pharmaceutical companies, and biotech firms looking to enhance their molecular interaction analysis capabilities.
1. Development and maintenance costs for the platform
2. Marketing and sales expenses
3. Customer support and training costs
1. Subscription fees for platform usage
2. Licensing fees for API integration
3. Customization fees for tailored workflows
Feedback
0 commentsPlease log in to leave a comment
Log In